4.7 Article

Synthesis and characterization of conducting polymer/alginate composite hydrogels: Effect of conducting polymer loading on the release behaviour of metformin drug

Journal

JOURNAL OF MOLECULAR LIQUIDS
Volume 372, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.molliq.2022.121193

Keywords

Alginate; Conducting polymers; Release kinetics; Rheology; Metformin hydrochloride

Ask authors/readers for more resources

In this study, sodium alginate-based composite hydrogels using polyaniline (PANI), poly(o-phenylenediamine) (POPD), poly(1-naphthylamine) (PNA), and poly(vinylidene fluoride) (PVDF) were synthesized and characterized. The hydrogels were investigated for their spectral, morphological, and rheological properties. Metformin hydrochloride (MFH) was used as a model drug, and the release profiles were studied using intestinal fluid pH of 7.4. The incorporation of conducting polymers as crosslinking agents significantly affected the release behavior, which could be used to optimize and control the release of metformin hydrochloride.
The present study reports synthesis and characterization of sodium alginate (Na-ALG) based composite hydrogels using polyaniline (PANI), poly(o-phenylenediamine) (POPD), poly(1-naphthylamine) (PNA), and poly (vinylidene fluoride) (PVDF). The synthesised hydrogels were investigated for their spectral, morphological and rheological properties. Metformin hydrochloride (MFH) was chosen as a model drug to study the release profiles using intestinal fluid pH of 7.4. Approximately 99 % drug release was attained for POPD/Na-ALG at 37 degrees C over a period of 12 h. Release kinetics was confirmed by employing the zero-order, first-order, Higuchi and Korsmeyer-Peppas models. It was found that almost all composite hydro-gels followed the zero order and Korsmeyer-Peppas models. The incorporation of conducting polymers as crosslinking agents was found to have a significant impact on the release behaviour and this property could be utilised to optimise and control the release of metformin hydrochloride as per desirable dosages.(c) 2022 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available